GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 223 filers reported holding GENMAB A/S in Q4 2020. The put-call ratio across all filers is 1.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $231,477 | -8.6% | 6,563 | -1.5% | 0.00% | 0.0% |
| Q2 2023 | $253,185 | -0.9% | 6,661 | -1.5% | 0.00% | 0.0% |
| Q1 2023 | $255,371 | -11.9% | 6,763 | -1.1% | 0.00% | -33.3% |
| Q4 2022 | $289,879 | -80.2% | 6,840 | -85.0% | 0.00% | -76.9% |
| Q3 2022 | $1,466,000 | -6.0% | 45,639 | -4.9% | 0.01% | +8.3% |
| Q2 2022 | $1,559,000 | -3.6% | 47,999 | +7.4% | 0.01% | +20.0% |
| Q1 2022 | $1,617,000 | -4.7% | 44,707 | +4.2% | 0.01% | +11.1% |
| Q4 2021 | $1,697,000 | -9.8% | 42,906 | -0.3% | 0.01% | -18.2% |
| Q3 2021 | $1,882,000 | +4.6% | 43,055 | -2.3% | 0.01% | 0.0% |
| Q2 2021 | $1,800,000 | +32.5% | 44,085 | +6.5% | 0.01% | +22.2% |
| Q1 2021 | $1,359,000 | +20.5% | 41,407 | +49.2% | 0.01% | +28.6% |
| Q4 2020 | $1,128,000 | – | 27,745 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 242,848 | $9,169,940 | 3.80% |
| Capricorn Fund Managers Ltd | 110,643 | $4,177,880 | 1.28% |
| Arlington Capital Management, Inc. | 35,591 | $1,343,916 | 1.26% |
| XY Capital Ltd | 76,884 | $2,903,140 | 1.13% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 88,000 | $3,322,880 | 0.93% |
| TORRAY INVESTMENT PARTNERS LLC | 110,807 | $4,184,072 | 0.75% |
| Hardman Johnston Global Advisors LLC | 585,139 | $22,094,849 | 0.72% |
| Yorktown Management & Research Co Inc | 16,600 | $626,816 | 0.68% |
| First Light Asset Management, LLC | 160,025 | $6,042,544 | 0.54% |
| MIRABELLA FINANCIAL SERVICES LLP | 28,260 | $2,505,855 | 0.38% |